The Texas MPN Workshop: Second Annual Workshop and Meeting will take place from 19 - 20 August 2021 as a virtual event, bringing together leading experts to share the most recent and exciting new developments in the field of myeloproliferative neoplasms (MPNs), covering areas including novel JAK inhibitors, drivers of progression, clinical trial updates and more.

View all videos

Texas MPN Workshop 2021

The Second Annual Workshop and Meeting

19–20 August 2021 | Virtual Meeting

; VJHemOnc @VJHemOnc ·

17h 1730512124806353143

#IMS23 | @OcioEnrique of @HUnivValdecilla shares safety and efficacy results from the ANCHOR trial.

Watch the interview here:

👉 👈

#TrialUpdate #CTSM #MultipleMyeloma #MMSM #HemOnc #ImmunoOnc @Myeloma_Society

Efficacy and safety results from the ANCHOR trial

Enrique Ocio, MD, PhD, Marquis of Valdecilla University Hospital, Santander, Spain, shares efficacy and safety results ...

ow.ly

Reply on Twitter 1730512124806353143 Retweet on Twitter 1730512124806353143 0 Like on Twitter 1730512124806353143 2 View Tweet 1730512124806353143

; VJHemOnc @VJHemOnc ·

30 Nov 1730285688573042876

#ASH23 is next week and we’re looking forward to interviewing KOLs in #HemOnc.

Unable to attend on 9th-12th December? We'll be bringing you exclusive insights into this year’s meeting on http://VJHemOnc.com!

@ASH_hematology #MDSsm #LymSM #LeuSM #DLBCL

Reply on Twitter 1730285688573042876 Retweet on Twitter 1730285688573042876 0 Like on Twitter 1730285688573042876 6 View Tweet 1730285688573042876

; VJHemOnc @VJHemOnc ·

30 Nov 1730149682523873761

Post-ASH Virtual Highlights Series, feat presentations & discussions on selected abstracts from 65th #ASH23 Annual Meeting 💻🩸

Webinars led by: @Daver_Leukemia, Bijal Shah, @Dr_AmerZeidan, @harrisoncn1, @mvmateos & John Gribben

REGISTRATION OPEN👉https://www.vjhemonc.com/feature/post-ash-2023-highlights/

Reply on Twitter 1730149682523873761 Retweet on Twitter 1730149682523873761 0 Like on Twitter 1730149682523873761 2 View Tweet 1730149682523873761

; VJHemOnc @VJHemOnc ·

30 Nov 1730134640906653844

🎥 Lisa Leypoldt of @UKEHamburg comments on the findings of the Phase II GMMG-CONCEPT trial of Isa-KRd in high-risk NDMM.

Watch here:

👉

#TrialUpdate #CTSM #MultipleMyeloma #MMSM #IMS23 #HemOnc #ImmunoOnc @Myeloma_Society

GMMG-CONCEPT trial: Isa-KRd in high-risk newly diagnosed multiple myeloma

In this video, Lisa Leypoldt, MD, University Medical Center Hamburg, Hamburg, Germany, shares results from the Phase ...

ow.ly

Reply on Twitter 1730134640906653844 Retweet on Twitter 1730134640906653844 1 Like on Twitter 1730134640906653844 2 View Tweet 1730134640906653844

; VJHemOnc @VJHemOnc ·

29 Nov 1729908210314645951

#COSTEM23 | Riccardo Saccardi of @AOUCareggi gives an insight into the impact various conditioning regimens have on the outcomes of patients with autoimmune diseases.

Watch here:

👉 👈

#HemOnc @COSTEMCongress

The impact of conditioning regimens on the outcomes of patients with autoimmune diseases

Riccardo Saccardi, MD, Careggi University Hospital, Florence, Italy, discusses the impact of various conditioning regimens...

ow.ly